William A. Garland
Corporate Officer/Principal chez JAWA Enterprises
Profil
William A.
Garland is currently a Principal at JAWA Enterprises.
Previously, he worked as a Senior Director at Hoffmann-La Roche, Inc. from 1974 to 1994, and as EVP-Pharmaceutical Development at Centaur Pharmaceuticals, Inc. from 1994 to 2000.
From 2002 to 2008, he was Vice President-Drug Development at Lpath, Inc. He also served as Chief Executive & Operating Officer at AngioGenex, Inc. from 2008 to 2012.
Additionally, he held the position of Vice President-Scientific Affairs at LPL Technologies, Inc. Dr. Garland holds a doctorate degree from the University of Washington and undergraduate and doctorate degrees from the University of San Francisco.
Postes actifs de William A. Garland
| Sociétés | Poste | Début |
|---|---|---|
| JAWA Enterprises | Corporate Officer/Principal | - |
Anciens postes connus de William A. Garland
| Sociétés | Poste | Fin |
|---|---|---|
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 22/09/2008 |
| Centaur Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/2000 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Directeur/Membre du Conseil | 01/01/1994 |
LPL Technologies, Inc.
 LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | Directeur Technique/Scientifique/R&D | - |
| ANGIOGENEX, INC. | Directeur Général | - |
Formation de William A. Garland
| University of Washington | Doctorate Degree |
| University of San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
| Centaur Pharmaceuticals, Inc. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
AngioGenex, Inc.
 AngioGenex, Inc. Pharmaceuticals: MajorHealth Technology AngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra in March 1999 and is headquartered in New York, NY. | Health Technology |
LPL Technologies, Inc.
LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | Health Services |
| JAWA Enterprises |
